Open Access iconOpen Access

ARTICLE

crossmark

CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma

CHUAN JIANG1,2, CHUNLEI LIU1,3, XI YAO1,3, JINGYA SU1,2, WEI LU1,3, ZHENGBO WEI3,*, YING XIE1,2,*

1 Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry ofEducation, Nanning, 530000, China
2 Life Sciences Institute, Guangxi Medical University, Nanning, 530000, China
3 Department of Head and Neck Tumor Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530000, China

* Corresponding Authors: ZHENGBO WEI. Email: email; YING XIE. Email: email

TSP_OR_52244.pdf

  • 944

    View

  • 152

    Download

  • 0

    Like

Share Link